These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37682979)

  • 1. Antileishmanial potentials of azacitidine and along with meglumine antimoniate on Leishmania major: In silico prediction and in vitro analysis.
    Derakhshani A; Sharifi I; Salarkia E; Keyhani A; Agha Kuchak Afshari S; Iranmanesh B; Lashkarizadeh M; Nejad Biglari H; Lari Najafi M; Bamorovat M
    PLoS One; 2023; 18(9):e0291321. PubMed ID: 37682979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico and in vitro antileishmanial effects of gamma-terpinene: Multifunctional modes of action.
    Nooshadokht M; Mirzaei M; Sharifi I; Sharifi F; Lashkari M; Amirheidari B
    Chem Biol Interact; 2022 Jul; 361():109957. PubMed ID: 35472413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
    Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative properties of Turmerone on Leishmania major: Modes of action confirmed by antioxidative and immunomodulatory roles.
    Mohseni F; Sharifi I; Oliaee RT; Babaei Z; Mostafavi M; Almani PGN; Keyhani A; Salarkia E; Sharifi F; Nave HH; Bamorovat M; Alahdin S; Sarlak M; Tavakoly R
    Comp Immunol Microbiol Infect Dis; 2022 May; 84():101797. PubMed ID: 35325685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stachys lavandulifolia Vahl. exhibits promising in vitro and in vivo antileishmanial activity against Leishmania major infection.
    Alanazi AD; Albalawi AE; Almohammed HI; Shater AF
    Trop Biomed; 2022 Sep; 39(3):412-420. PubMed ID: 36214438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.
    Shokri A; Sharifi I; Khamesipour A; Nakhaee N; Fasihi Harandi M; Nosratabadi J; Hakimi Parizi M; Barati M
    Parasitol Res; 2012 Mar; 110(3):1113-7. PubMed ID: 21847598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling.
    Oliaee RT; Sharifi I; Bamorovat M; Keyhani A; Babaei Z; Salarkia E; Tavakoly R; Khosravi A; Mostafavi M; Sharifi F; Mousavi SM
    Int Immunopharmacol; 2020 Sep; 86():106704. PubMed ID: 32590317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial, cellular mechanisms, and cytotoxic effects of green synthesized zinc nanoparticles alone and in combined with glucantime against Leishmania major infection.
    Ghasemian Yadegari J; Khudair Khalaf A; Ezzatkhah F; Shakibaie M; Mohammadi HR; Mahmoudvand H
    Biomed Pharmacother; 2023 Aug; 164():114984. PubMed ID: 37321058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the antileishmanial activity of diallyl sulfide combined with meglumine antimoniate on Leishmania major: Molecular docking, in vitro, and animal model.
    Zarrinkar F; Sharifi I; Salarkia E; Keyhani A; Babaei Z; Khamesipour A; Hakimi Parizi M; Molaakbari E; Sharifi F; Dabiri S; Bamorovat M
    PLoS One; 2024; 19(8):e0307537. PubMed ID: 39213335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum.
    Adinehbeigi K; Razi Jalali MH; Shahriari A; Bahrami S
    Pathog Glob Health; 2017 Jun; 111(4):176-185. PubMed ID: 28385129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
    Moosavian SA; Fallah M; Jaafari MR
    Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico and in vitro inhibitory potential of an organometallic Cu (II) complex on Leishmania major stages.
    Mirzaei M; Nadushan AS; Nooshadokht M; Abiri A; Anjomshoa M; Sharifi I; Amirheidari B
    Ann Parasitol; 2021; 67(1):45-54. PubMed ID: 34021979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the
    Azadi R; Alipour-Talesh G; Yazdanpanah MJ; Alavizadeh SH; Maleki M; Banihashemi M; Jaafari MR
    J Vector Borne Dis; 2020; 57(1):78-84. PubMed ID: 33818460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent in vitro antileishmanial activity of a nanoformulation of cisplatin with carbon nanotubes against Leishmania major.
    Akhtari J; Faridnia R; Kalani H; Bastani R; Fakhar M; Rezvan H; Beydokhti AK
    J Glob Antimicrob Resist; 2019 Mar; 16():11-16. PubMed ID: 30244039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biosynthetic zinc oxide nanoparticle and glucantime cytotoxic effects on Leishmania major (MRHO/IR/75/ER).
    Saleh F; Kheirandish F; Abbasi M; Ahmadpour F; Veiskarami S; Mirderikvand A
    J Basic Microbiol; 2024 May; 64(5):e2300490. PubMed ID: 38227394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl gallate: Selective antileishmanial activity correlates with host-cell directed effects.
    Noleto Dias C; Nunes TAL; Sousa JMS; Costa LH; Rodrigues RRL; Araújo AJ; Marinho Filho JDB; da Silva MV; Oliveira MR; Carvalho FAA; Rodrigues KADF
    Chem Biol Interact; 2020 Apr; 320():109026. PubMed ID: 32112863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of
    Mahmoudvand H; Kheirandish F; Mirbadie SR; Kayedi MH; Rezaei Riabi T; Ghasemi AA; Bamorovat M; Sharifi I
    Iran J Parasitol; 2017; 12(3):339-347. PubMed ID: 28979343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages.
    Valentim-Silva JR; Macedo SRA; de Barros NB; Dos Santos Ferreira A; da Silva JHM; de Figueiredo Nicolete LD; Nicolete R
    Int Immunopharmacol; 2020 Aug; 85():106640. PubMed ID: 32470884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.